Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Finland
Sweden
Denmark
Norway
Latest
Trending
Followed

Asker Healthcare, Audiocast, Q4'25

By Inderes2/10/2026, 9:00 AM
Asker Healthcare

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Johan Falk
00:01 - 04:52

Thank you, and welcome to our Q4 presentation for Asker. I'm happy to present another robust earnings growth quarter for us. You know, I usually say that one of the best markets to be in is medical supplies, devices and equipment. And regardless of how nervous the world is or how financially challenging the climate is, we never give up helping our loved ones from when we are born until we pass away. We need these supplies. And that's what makes this fantastic market very stable. Q4 isolated. If we just summarize it first, we had a good quarter, despite the headwind from tough comps in North and FX, net sales were up 9% to 4.7 billion. Adjusted EBITDA increased by 16% to 470 million, driven by strong performance in West and Central especially. And we have some tough comps, as I mentioned, in North, and the underlying business to regions, municipalities, and private players. Players in Nordic are still very strong. But, once in a while, you get these extra orders from different areas this time. In 2024, we had deliveries to the Ukraine war and preparedness across the Nordic regions. So the comps were a bit tough, but the underlying business is performing well. I'm happy to say that we reached the EBITDA margin of 10%. As you know, that's one of our financial targets. Q4 is the strongest quarter of the year. So, we will see some weaker numbers for a while, but it's always good to feel that you can break the ceiling of 10%. So we're very proud of that. Our cash flow was very good in the quarter as well. Even though we did four acquisitions in the quarter and a total of 14 during the full year, our leverage maintained at 2.26, which is good. And we have a very, very strong pipeline for new acquisitions coming in the next year. Oops. Q4 isolated. Thank you, and welcome to our Q4 presentation for Asker. Looking at the full year, the best way to follow Asker as an investor, or if you're interested in our company, is to look at the rolling 12 months. I would say it's a stable, slow-moving, but in the right direction. And we're proud to see that we're exceeding our financial targets. The most important promise I have to you as investors is the adjusted EBITDA growth of over 15%. And despite the headwind and tough comps, we have 17% growth, which I'm very happy to see, and the overall R/RK, an operationally important measure for being a Working Capital Light Company. And our Adjusted EBITA margin is on a stable level on a rolling 12 months, even though we reached 10% in Q4, the rolling 12 is 9.5% and continues to increase, which is good to see. Net debt of 2.26x, giving us headroom together with the strong cash flow to continue our M&A journey for the first time as a listed company, and the board proposed a dividend of 30%, which is up 3.90 per share. Looking at the longer time series, which I like to do because this is, I've been in for many, many years and hopefully many years to come as well. We have a very exciting future ahead of us consolidating this market, and we have seen well above 15% CAGR over the years, quarter by quarter. And I know that some people are a bit nervous with one quarter and tough comps coming in, but the underlying business is performing very well. The twin engine, as we call it, with organic growth as the highest priority to grow faster than the market and get some efficiency gains together. Then fueling the second engine of M&A has delivered quarter by quarter growth above 15%, which we are looking forward to deliver as well going forward. So that's the summary of the quarter. I'll leave the word to you, Tom, to go through the detailed financials.

Thomas Moss
04:53 - 12:44

I'll leave the word to you, Tom, to go through the detailed financials. Thanks, John. Let's go through the numbers in a bit more detail, just to add some color to what Johan has said. So if I start with the group as a whole, Net Sales in Q4 up 9%, of which -1% organic, -4% from FX, and the Adjusted EBITA in Q4 up 16%, of which -3% organic and -3% from FX. I'll come back to the different regions in a little bit more detail in a second. But as Johan said, the big picture, the big story is of course, good, solid performance both in West and Central and moderated by those tough comps in North. I think the important thing from our perspective is to be comfortable that the underlying organic growth is very much for us to deliver on that target to be faster than the market. And if we make that adjustment for those tough comps in 2024, we're confident that we're still doing that. The other headline note, perhaps Johan touched on it, the EBITDA margin reaching 10% for the first time. There's always some variation between the quarters, and Q4 tends to be the strongest quarter of the year, but even so, a nice milestone for us to reach. And then if I turn to the right-hand side of this picture, the full year, very much in line with what we've seen all the way through the year and what we see in Q4: organic growth of Adjusted EBITA at 4%, strong contribution from acquired growth of 16%, and an FX headwind that we've had all year and was particularly strong towards the end of the year, at minus 3%. But overall, we're delivering Adjusted EBITA growth of 17%. And as Johan said, above our 15% external target. If I turn to the business areas one by one, let's start with business area north. Also here, important for us to be comfortable and confident that the core business, as Johan mentioned, continues to perform well. Obviously, the growth rate figures are significantly affected by the lower project-based sales that we've talked about a lot through the course of the year, and we estimate those to have been around 350 million of lower sales year on year as a result of that. But also important for us to repeat that we remain optimistic. We see this as an area of lots of activity going forward and lots of opportunity for us, but the timing remains uncertain. Also in North, we should just touch on the new distribution center that we've talked about progressing very nicely down in Gothenburg, putting in some of the automation and some of the other technical installations during the quarter, and going very well. We expect the operations to be up and running towards the second half of 2026, and then us really starting to get the efficiency gains and the benefits into the PNL during 2027. And then if we look at the full year numbers on the far right-hand side, again, I think no great surprise, the adjusted EBITDA growth down at 9% for the negative reasons that I've described and net sales down 4% in the region. Full year Business Area West: A strong performance from Region West. Net sales up 20%, adjusted EBITDA up 36% in Q4 and the margin moving nicely above 9%. And actually, when we look at Region West, we see a very broad base of activity and improvements across the countries and across the companies in the region, both that strong focus on organic growth and operational improvements. Plus, of course, the very positive contributions from the M&A we've completed, particularly the larger deals like HSL Group, which we acquired at the beginning of 2025, and Scan Modul, which came in during the middle of 2025. Both of those and all the other M&A contributing very strongly to the region. Small note, we did have some one-off costs relating to warehouse reorganization in the Netherlands. That money has now been spent and was a temporary effect just here in Q4. So that affects the organic EBITDA growth a little in the quarter, but we expect to see the efficiency benefits of that coming through during 2026 full year figures on the right hand side. Good to see adjusted EBITDA growth at 39%. Net sales growing at 20% on a full year basis. And then turning to our third region, Region Central. Also a strong performance in Region Central. Net sales up 17%. Adjusted EBITA up 44% in the quarter. And it is also pleasing to see the margin moving again above 9%. As I've talked about before, we've really focused on driving margin in Region Central, and it's good to see that both the newly acquired companies have performed strongly. They really help improving the margin mix, but they also, of course, help with the top line and the growth in the region. But actually, the organic focus on margin improvements in some of our older businesses in the region is also bearing fruit. We see those efficiency benefits coming through and a focus on phasing out some lower margin product categories in some of our companies. On a full year basis, adjusted EBITA growth up 52%, with a significant portion of that, of course, coming from the acquired growth. But organic growth also delivering very strongly for Region Central during the year. And then net sales growth was a little slower, with organic growth also being somewhat slower there. But as I've said, we are occasionally happy to sacrifice a little bit of growth to get the margins up. And that's what we've seen in Region Central. A brief word on R/RK (EBITA/NWC), our key internal performance metric, keeping the organization, keeping the operations focused on cash and cash delivery. Happy to see that that is maintained at a high level. I've talked about it before, but we're always pulled in two directions on this metric because the M&A that we do tend to have a lower working capital efficiency, working capital utilization efficiency, and we're constantly diluting the overall group picture. But we're working to improve things the whole time. So as those two things pull in different directions, to deliver a flat result on an ongoing basis is actually something that we're very happy with. It shows that the business is working and focusing on the right things and generating plenty of cash that we use to fuel the M&A engine that Johan mentioned. And actually that we can see a little bit of here on the next page when we look at the cash flow, solid cash flow, full year and in Q4, the good performance on the top line, of course, contributing to that. But also, as we keep emphasizing this real focus on working capital efficiency, delivering full year CapEx running at a slightly higher run rate than I think is normal for this business. We've also talked about the big new investment in the warehouse in Gothenburg, which is progressing nicely. And then you also see on this page, we had a relatively high level of acquisitions in 2025 post IPO. But that was funded to some extent by the equity that we took in during the IPO that you see on the financing line on this slide. And then just one more from me before I hand it back to Johan. Stable leverage just below 2.3. Also pleasing to see that this part of the model is working well for us. Giving us the capacity to continue to drive the acquisition agenda using our own cash flow. We obviously remain extremely committed to our 2.5x threshold, and we're confident that we can manage that continued acquisition agenda and use our strong own cash flows to continue to buy interesting and exciting businesses around Europe. And with that, I hand it back to you, Johan.

Johan Falk
12:45 - 17:53

Thanks, Tom. And actually that we can see a little bit of here on the next page when we look at the cash flow, solid cash flow, full year and in Q4, the good performance on the top line, of course, contributing to that. Talking a little bit more about acquisitions. Our second engine, 2025, was an exceptional year. We had a little bit extra cash coming from the IPO where we used this to buy three platform acquisitions, as you know. So that activity has been a little bit above normal. But 14 signed acquisitions in 2025. And we entered into four new countries and new markets, continuing with a strong pipeline going forward. So I think we now have come halfway to a fully consolidated Europe. We are now present in 19 markets and very, very nice and interesting years ahead of us. Continue our journey being the market leader in this, this market. It has been very good to see how we can attract the best niche players across Europe in different markets, and being very disciplined when it comes to quality of the business, quality of management, and also being disciplined on multiples. As we have mentioned before, we usually pay 6 to 8 times for normal deals, a little bit more for bigger platforms. But that has been very, very good to see that our strategy continues to deliver. If we dig down into two examples, which is good to do. It's all about numbers in this quarterly report, but for us, it's delivering some 70,000 boxes per day, ending up at the nurses' and doctors' offices with critical products and solutions. And one of those companies is Van Heek Medical. The first one that I'm going to present is in the same area that we are very strong already in the Netherlands. They are a leading provider of medical supplies in the Benelux region. They've been around for a very long time, actually since 1926. This is a good example of how we sometimes buy three-generation companies with very good and stable business in their own niche. And this company provides branded and private label medical supplies for diabetes, incontinence, and wound care, primarily to home care, pharmacies, and nursing homes in the Benelux region. Some 350 million in revenue and a little bit more than 60 employees. So it's a good representation of how an acquisition can look like, also a positive addition to our EBITDA margin. The next example is Innomedicus. This is a more niche company, highly niched actually within urology and prostate cancer, selling to specialists across Europe. And here. Here is a good example of how it's not only about supplies, devices and equipment, but rather the competence in a therapeutic area where you need a mix of products, a mix of services and also expertise in software and solutions. So, being a partner to healthcare, you need to be an expert in understanding the nurses' and doctors' everyday lives and put together a basket of solutions and expertise that makes their lives easier. And that's the type of company we buy. And together, we're now more than 60 companies. We're becoming stronger as a group, using the efficiency and scale to be able to attract more companies and help the healthcare sector in a good way. So two good examples, and we're very happy to have them on board. So, to summarize Q4, it was a solid quarter with adjusted EBITA growth of over 16%, achieving an EBITA margin of 10%, which is great to see, alongside strong development in West and Central driven by acquisitions and operational improvements. And as Tom and I have mentioned, the tough comps in North is, of course, disappointing that we didn't get those deals that we got in 24. But going ahead, we think that this area could come in with some very attractive deals in the future as well. 14 signed acquisitions, all of them margin accretive. So we're happy to see that the companies we buy actually have a positive mix effect on our EBITDA margin as well. So all in all, a good year, and we continue to deliver on our twin-engine strategy with a strong cash flow, which is very, very important. We see no reason why 2026 shouldn't be as exciting as previous years as well. So with that, I think we stop the summarizing part and go to Q&A.

Operator
17:55 - 18:13

If you wish to ask a question, please dial Pound Key on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial Pound Key on your telephone keypad. The next question comes from Carl Ragnerstam from Nordea. Please go ahead.

Carl Ragnerstam
18:15 - 18:44

Good morning. It's a couple of questions. Firstly in North, quite impressive margins standalone, but especially adjusting for the defense volumes as you also mentioned. Can you help us understand a bit the margin drivers to this delta? Was it the positive mix in the quarter, with smaller, higher-margin products, and also especially if you compare it to the Q3 margin, that was quite a bit lower, right?

Thomas Moss
18:46 - 20:00

Should I take that one? Yeah. Thanks, Carl. Good question. I think the slightly trite and simplistic answer is you might have expected the margin to dip a little bit in North year on year because we have lost or have not repeated some of the GD business, which does come in at slightly higher margins. The reality is actually the rest of the business has been doing very well. It has had a good quarter. When I dive into the details of individual companies and individual areas within individual companies, we see a broad-based, strong performance across the core distribution operations. And there are no big one-off effects that are driving that; fundamentally, our core operations in North are capable of delivering 13-14% EBITDA margin. Q4 is always the strong quarter. I think that's always to note, and especially when you do a sequential comparison, you go from the weakest quarter Q3 to the strongest quarter Q4. So that you perhaps shouldn't read too much into that. But if you look over the 12 months, the northern region, even without GD, is capable of delivering 13, 14% EBITDA margin, and that's pleasing for us to see.

Carl Ragnerstam
20:02 - 20:33

Now, that's very clear. And looking into North, you had the 175 million top line impact on organic sales, meaning that underlying organic growth in North is low single digits, I guess, entering Q1, do you see any reasons why that pace shouldn't be kept? The underlying pace, that is, given that we are exiting all of the defense comps in Q1.

Thomas Moss
20:33 - 21:14

I can perhaps say a few words about that as well. Obviously, there is still uncertainty about the timing of this new lumpy business that we still expect and hope to see. But I do think that the fundamentals in North are very stable, the business is moving in the right direction, and we are doing lots of the right things across all of our companies and all of our countries in North. So, if we take a step back and view North without the lumpiness, you know, there's no reason to expect some dramatic acceleration or deceleration in the fundamental momentum in North. No.

Johan Falk
21:16 - 22:14

Maybe in addition to that, I think we have a good 2026 ahead of us where we will hopefully over deliver on our financial targets, as we have done many, many years before. But we should also say that we are investing in the warehouse, which, of course, is a very exciting thing to see. This business is ultimately about efficiency, scale, robustness, and to allow ourselves to invest as we do in Gothenburg and other areas. I think that's an important part of it. So that will of course affect us a little bit when you do such a big thing. But the underlying business is once again stable and robust. But you can expect that, with this investment, of course, it will cause some disturbance. Some disturbance in some quarters could happen. Not to raise expectations too high, but nothing spectacular.

Carl Ragnerstam
22:17 - 22:35

Okay. That is very clear. Then, in West, you have the new logistics center. What is the net sales and EBITDA impact from the ramp-up of that, and do you expect it to continue into Q1 as well?

Thomas Moss
22:36 - 22:41

Sorry, I missed the last sentence; could you say it again?

Carl Ragnerstam
22:42 - 22:56

What was the sales and EBITDA impact from the ramp-up of the new logistics center in the Netherlands during the quarter? And do you expect the elevated cost in Q1 as well?

Thomas Moss
22:57 - 23:19

The next question comes from Albin Nordmark from SEB Markets. Yeah. So the sales impact was minimal, effectively zero. We took approximately a little bit less than €1 million of cost. Extra cost in the quarter. That weighs down the result a little bit in West in the quarter, but that's money that's spent. There is no continuation of that cost coming into 2026. So the reorganization is done.

Carl Ragnerstam
23:22 - 23:25

Okay. Very clear. That's all for me. Thank you, thank you.

Johan Falk
23:25 - 23:26

Thanks, Paul.

Operator
23:30 - 23:34

The next question comes from Albin Nordmark from SEB Markets. Yes, I can take that.

Albin Nordmark
23:37 - 23:58

Yes. Good morning, Johan and Tom. Just wanted to comment on CapEx. So, quite high historically at 223 million and 3.5% of sales. So obviously Gothenburg and the new warehouse in Netherlands are some of that. But can you give us any guidance of what to expect here, entering 2026?

Thomas Moss
23:59 - 24:21

Yes, I can take that. The total cost of the warehouse in Gothenburg is approximately 300 million SEK. And approximately half of that cost has now come in 2025. The other approximately 150 million will be spread out relatively evenly through the rest of 2026.

Albin Nordmark
24:31 - 24:36

And we've spent approximately half of that cost in 2025. So 150 million for 2026. But the CapEx as a whole, then.

Thomas Moss
24:37 - 25:16

CapEx as a whole, this is a relatively CapEx light business on an ongoing basis. So generally, we don't have big bits of equipment, machinery, those sorts of things. Our heaviest investment is in, for example, the high-tech automation machine, which represents a big chunk of the CapEx going into the warehouse in Gothenburg. So once that's gone, we should return back to a more normal CapEx level, which I estimate will be somewhere around 2% of revenue. That's the that's the kind of rough run rate. And of course, it will vary a little bit down over time. But under normal circumstances, that's roughly where we should be.

Albin Nordmark
25:18 - 25:39

The total cost of the warehouse in Gothenburg is approximately 300 million SEK. The total cost of the warehouse in Gothenburg is approximately 300 million SEK. The total cost of the warehouse in Gothenburg is approximately 300 million SEK. And then just looking at node two here, I noticed some changes in accounting for goods and services this quarter versus the last quarter's, so now we see that services is some 21% of sales. So please comment on that.

Thomas Moss
25:40 - 26:10

That's just a technical change in definitions. There is no real change in the business. It's always a slightly arcane Note 2 is a technical note, which I'm not sure is especially revealing, but we had a technical change in definition in one of our larger units, which explains the change. But there's no fundamental change in the actual business underlying it.

Albin Nordmark
26:12 - 26:15

All right. So, the total cost of the warehouse in Gothenburg is a little bit more than 300 million, approximately 300 million SEK. And that's all for me. Thanks a lot.

Operator
26:22 - 26:26

The next question comes from Jakob Lemke from Seb. Yes.

Jakob Lemke
26:29 - 27:03

Yes. Yes. Hi, and good morning. My first question, I want to come back to the profitability in North here in the quarter. The way I have understood it is that these defense sales you've had in the past have quite strong profitability. And given that you lose that year over year, the implication is that the underlying profitability in North is actually very strong. So I'm wondering if you could come back and highlight what initiatives that have driven this. What is behind that really.

Thomas Moss
27:03 - 28:15

Yeah. I think you're right in terms of the way you read the numbers, Jakob. So, the defense and preparedness contracts have typically been higher margin than the average. When we look into the numbers, they were slightly lower, but still amounted to a higher margin in Q4. Year on year. But net net. I think that's an important topic. You might have expected the loss of those to have resulted in a lower margin in Q4. But I come back a little bit to the answer I gave to Carl earlier. It is quite broad based across the operations, across the companies, across the markets. Q4 is typically a strong margin quarter. But there isn't actually one individual or even just 2 or 3 small individual elements that have contributed to that. Fundamentally, the business in North, with its combination of companies and customers, is capable of delivering a 13-14% margin. So I understand it would, in a way, be easier if I could point to one or two initiatives that have driven that. But actually, it's relatively broad-based across our operations and countries in North.

Jakob Lemke
28:18 - 28:48

Okay. That's that's understood. I also follow up on the margin in North. As was mentioned previously, it's a quite big step up from Q3. And I think you were at around 14% also for the first half of this year. So the question is really, would you say the sort of margin between the quarters here in 2025 is representative for 2026 or. Yeah. How should we think about the seasonality?

Thomas Moss
28:49 - 29:51

I think that's an important topic. So Q3 is always our weakest quarter. It's from a margin perspective without being too simplistic about it. It's driven by the holiday period. We have a business that is a little bit quieter through that extended Nordic holiday period. And Q3 is the lowest margin quarter, Q4 is the highest margin quarter. So when you try to do that sequential analysis, it sometimes looks like there is a sort of a big jump or something has changed in the business. The reality is it hasn't. It's simply about the amount of volume that is flowing through our operations. I would also say that 2025 has been a year where we haven't had very much of the lumpiness on top from the preparedness contracts. So when you look at the margin profile in Region North in 2025, you have quite a good picture of what a normal underlying margin in North would be through the course of a year.

Jakob Lemke
29:54 - 30:07

Okay, but just a follow up. I guess you would do lower volumes in Q1 compared to Q4. And should we also assume that you will have lower margins in Q1 compared to Q4?

Thomas Moss
30:07 - 30:27

Yes. If you look over the year, the margin doesn't wildly, dramatically change, and certainly internally we're always looking at rolling 12, as Johan mentioned. But Q3 is the weakest margin. Q4 is the strongest margin. Sequentially, the margin in Q1 will always be lower than the margin in Q4. All else equal.

Jakob Lemke
30:30 - 30:48

Okay, that's very clear. My next question is on West, where, if I get it correctly, I sense that the organic EBITA growth if you remove this one-off cost is around mid-single digits here in Q4. And is that a reasonable level to expect going forward?

Thomas Moss
30:49 - 30:51

That's a reasonable conclusion to come to. Yes.

Jakob Lemke
30:54 - 31:09

Okay, good. And then also, if you would like to comment on the profitability in Central, which I think looks strong, both driven by acquisitions and on an organic basis, if there's something behind that.

Thomas Moss
31:10 - 32:34

Yes, I can maybe take that one. The observation is right. The same applies for Central as it does for the other regions. Q4 tends to be the strongest margin quarter, I would say, and I think we've mentioned this a little bit in the past as well. We have had a strong focus on margin in Business Area Central. It's been a key topic for the leadership down there. We've been looking at how we rationalize the range, how we take out low margin products, how we start to gain some benefits of economies of scale. And we have got a particularly positive mix benefit coming in from the M&A that we've done in Central as well. So it's a combination of factors that we are happy to see are bearing fruit. Typically, when we look across the group as a whole, when we do our five-year backward-looking analysis on margin, we see that approximately half the margin benefit comes from M&A mix, and approximately half comes from our organic operational efficiency programs. Now that will vary quarter by quarter, region by region. It will vary a bit over time. But if you want a little bit of guidance to think about where margin improvements coming from, very, very simplistically and very crudely, it's about half from M&A mix and half from organic activities.

Jakob Lemke
32:37 - 32:57

Okay, good. And then, finally, coming back to a question on the capital expenditure, if you disregard all of this CapEx for the distribution center, would you say that that is a sort of normalized level that we can expect going forward?

Thomas Moss
32:58 - 33:50

Yeah, I think so. We've discussed this here as well, whether that's appropriate to do, because as this business grows, as Johan mentioned, we will look to drive economies of scale. We will look to find consolidation activities. As you know, we run a highly decentralized model. So that's not our main focus. But over the medium term, there will be benefits to come from finding those consolidation activities. So you might argue that okay, it was the Gothenburg warehouse this year. Maybe it's a warehouse in Central Europe in three years' time or something. But yes, sort of simplistically short term, mathematically, if you take out the Gothenburg warehouse, you have a CapEx, which is sort of in line with our normal run rate. But I don't want you to take that to mean that I'm promising that we might not invest in another big new warehouse in three years' time, because we probably will.

Jakob Lemke
33:54 - 33:57

Yeah. Q4 tends to be the strongest margin quarter, I would say, and I think we've mentioned this a little bit in the past as well. That sounds fair. That's all for me. Q4 tends to be the strongest margin quarter, I would say, and I think we've mentioned this a little bit in the past as well.

Operator
34:03 - 34:07

The next question comes from Eric Castle from Danske Bank. Q4 tends to be the strongest margin quarter, I would say, and I think we've mentioned this a little bit in the past as well.

Eric Castle
34:09 - 34:41

Hi. Good morning everyone. First, I want to dwell a bit on your capacity to do M&A now in 2026. First, if we're looking at the sort of debt items outside of your definition of debt, as you know, contingents and put/call options, what's the sort of timing of payments you're seeing for those? Because that's close to a billion now. Just thinking, if they may hit now in H1, or we could expect, for example, a low M&A pace at the start of the year. Just generally anything on that would be helpful.

Thomas Moss
34:43 - 36:06

I can take that one. And good fair question. Eric. So we have approximately 450 million that will go out during H1 for Earnouts. So of that 900 plus that you referred to, approximately half of it will flow out in earn out payments. In H1 2026. Of course, you can imagine we're fully aware of that. We see that it's in all of our cash flow forecasting and our M&A agenda, and it's built into the models. So it's a core and regular part of the business. It's slightly higher this year than next year, because the remaining 450-500 million in that liability flows out over the next three years. So you can imagine that the amounts are a bit lower in 2027, 2028 and so on. But the answer to the heart of your question is no, we don't see that as a limiting factor. The business generates a lot of cash. It generates a lot of cash quickly. This is a well-known element of our model that we build in. And we're confident that we can do the 10 to 15 deals a year and achieve the ten plus percent. EBITDA extra contribution from M&A that we will achieve through the course of the year, maintain leverage below 2.5, and pay out the Earnouts. Sorry, that was a very long answer to your question. I hope it made sense.

Eric Castle
36:08 - 36:42

No, no. That's good, that's good. But on that as well, I noticed that the sort of proportion of contingent consideration within the acquisitions done was a bit higher than normal. So I just wanted to ask, now that we have another upcoming 500 million, regarding the acquisition pipeline. Now, recently, are you structuring these sort of deals any differently now with a smaller part of cash out to be able to keep pace with your M&A targets?

Johan Falk
36:43 - 38:00

No, I wouldn't say so. We have, over the years, bought 100% of the shares as a standardized deal with 70% to 80% payout at the start and then a 2- to 3-year earnout model. And that's where we are. And sometimes it's a bit more, sometimes a bit less. But we're not adjusting this to keep up the pace. As I understand your question regarding keeping up the pace by increasing our debt going forward, that's not the model. So we will have proportionately the same earnout payments and cash out every year. And since we're growing with 15% plus, we can continue to buy 15% more earnings. Everything scales up going forward. And we've done this now for over a decade with the same model. So I see no reason to be worried about that. So good cash flow. If anything, we're buying better and better companies, and our position is getting stronger. So looking five years ahead rather than five years backwards, I'm more positive to the future than I am the past, to be honest.

Thomas Moss
38:01 - 38:44

And actually, I can add, Derek, the trend is actually in the other direction, very, very slightly. As I say, when we have this conversation in July, when we've reported the Q2 numbers, the liability that sits, as we say, above 900 million today will sit at 500 million or something, because a large portion of it will have been paid out. The reason why there's quite a large chunk flowing out now is actually because a number of the businesses that came to the end of their earnout in 2025 have performed exceedingly well. It's a good sign for us. The businesses are doing well, they're contributing, and they continue to contribute and will continue to contribute going forward even after the end of the earnout period. So.

Johan Falk
38:44 - 39:22

And maybe the last comment here, our business is so stable and slowly moving in the right direction, which also means that we have very good visibility. Internally, we're discussing Q4 2026 and Q1 2027 regarding acquisitions. So for us, 2026 is almost history, even though we are just starting. So we have a very good visibility and control over our cash flow, thanks to the stable business and the headroom in our 2.5. So this is the least thing I think we should be worried about.

Eric Castle
39:24 - 39:52

Now, recently, are you structuring these deals any differently now with a smaller part of cash out to be able to keep the M&A pace consistent with your targets? And that was a great segue to my next question as well. Could you perhaps talk a bit about how you're viewing comps into 26 and also talk about how much potential volumes that we could see from defense? And if you think there's any areas of the business that will end up being mentioned when we have our end-of-year call next year as having been tough comps or something that sort of distorts the image of earnings that you've then reported.

Johan Falk
39:53 - 42:14

Yes. If I just start at a high level, then you can detail this. And I think, if we start with 2025. In 2024, it was a normal year when it came to acquisitions and operations. But we had this defense and Ukraine war that gave us some extra deals on top; 2025, unfortunately, did not have those deals to the same extent. We had some of the what we call GD orders, but not to the extent we had hoped for. In 2026, we hope that these orders will be realized during the year. But I'll be very clear to tell you when things are coming in. So we don't need to disappoint anyone. So, as I see it, the market value is 1,300 billion SEK. On top of this, we have some extra volumes coming from the defense right now. Back in the days we had it from Covid. And when these orders come, they tend to change the picture in comps. But the underlying business is the same. So hopefully we will get some extra of this business. But we will come back to it when and if it comes. The other part of this year will be this investment in Gothenburg, which could have a little bit of extra cost. My philosophy when doing this is so important to be robust in having dual tracks and the possibility to deliver to the customer regardless if there are some delays or problems, or maybe a little bit of extra cost could come in to that. Hopefully not, but I'm just saying what we see in the next year to come. And then hopefully we'll just continue to see some positive effect from our scale and growth. And if anything, I feel that when we now are a listed company, we're growing bigger. More and more suppliers are turning to us and want us to take on their lines; more and more customers are doing the same. Customers are turning to us. So I think every year it becomes a little bit better going forward. But I also don't want to raise expectations above our financial targets. But I have a good feeling for 2026, and there shouldn't be any extraordinary things this year. What do you say, Tom?

Thomas Moss
42:15 - 42:17

No, I think it's a good summary. I don't have anything to add.

Eric Castle
42:19 - 42:35

Can I just ask on a follow up? Is there any part of the business that you think is coming into 2026, like Homecare, for example, which invested really well in 2025? Do you think that will have challenging comparables in 2026? If you have any examples of that, I think that would be helpful.

Thomas Moss
42:36 - 43:14

I think it depends a bit how you think about it. So obviously, the organic growth in West in the first nine months of this year was boosted by increased patient numbers. So we shouldn't expect the same growth rates or the same extremely high growth rates. But it's not like this is going to go into reverse. That now is in the base. And we will continue to grow organically from that new base. So, it's tough in the sense that we can't deliver 15, 20% growth every quarter organically. But there's no reason why we shouldn't deliver four, five, or six percent organic growth from a new, higher base.

Johan Falk
43:14 - 44:27

And I think we should come back to our most important statement, our target to grow our earnings. Total earnings more than 15%. We feel very comfortable about going forward organically. We should grow faster than the market, which is growing with some three plus percent. That's why we're buying niche market leaders that perform that way. Of course, sometimes it goes a little up or down. But as a group, we have been doing that for many, many years. So that's what you should expect. And our bottom line EBITDA margin target of 10%. We are slowly but steadily going towards the 10% and breaking that ceiling, as we did in Q4 in total as well. Thanks to a favorable mix effect, we're buying companies with over 10% EBITDA margin, and we also get some scale effects and positive operational effects from the business. So however you do your Excel sheets, at the end of the day, make sure it comes to those conclusions, and anything that is extremely high or low, you should be relaxed about it because it usually comes to those conclusions and view this business over a longer term. That's the best advice from me.

Jakob Lemke
44:31 - 44:33

Do you think that needs to have challenging comparables in '26? Can I just ask a follow-up question? I'll jump back in here.

Operator
44:39 - 44:45

There are no more questions at this time. So I hand the conference back to the speakers for any closing comments.

Johan Falk
44:46 - 44:53

All right. Thank you so much. And I'll see you in three months time. Have a good day.

Continue to the webcast
Revenio Group Oyj, Q3'26
Language: English11/12/2026, 1:00 PM
Jukka Kainulainen Good afternoon, and welcome to the Revenio Group Corporation Q3 Earnings Call. My name is Jouni Toijala. I am the CEO. And then, again today we have Jukka Kainulainen, our CFO, on th…
Kamux, Q3'26
Language: English11/12/2026, 9:00 AM
Katerina Heterant Good morning. Welcome to the Kamux Q3 results presentation. My name is Katerina Heterant and I am Head of Investor Relations at Kamux. Today we shall go through the Q3 results presen…
Koskisen, Webcast, Q3'26
Language: Finnish11/12/2026, 8:00 AM
Jukka Pahta Hyvää huomenta ja tervetuloa tähän osavuosikatsaustilaisuuteen! Koskisen tammi–syyskuun osavuosikatsaustilaisuuteen lähdetään otsikolla: Koskisen liikevaihdon kasvu jatkui. Kohonneet kusta…
Reaktor, Q3'26
Language: Finnish11/11/2026, 9:00 AM
Pekka Horo Oikein hyvää aamupäivää kaikille ja tervetuloa tähän meidän webcastiimme. Olen Pekka Horo, Reaktorin toimitusjohtaja, ja kanssani täällä on tänään Antti Akkanen, joka aloitti lokakuussa Rea…
Savox, Q3'26
Language: English11/10/2026, 11:00 AM
Paulina Tanila Our speakers today are CEO Jerry Kettunen and CFO Juha Järvi. Jerry will give an overview of Savox as a company and go through the highlights of the quarter. After that, Juha will conti…
Raisio Oyj, Webcast, Q3'26
Language: Finnish11/10/2026, 10:00 AM
Elli Siltala Hyvää marraskuista päivää Raisiosta! Ja tervetuloa Raision tammi-syyskuun 2026 osavuosikatsauksen webcastiin! Pahoittelut pienistä teknisistä haasteista, mitä meillä oli tässä alussa. Min…
Mandatum Oyj, Audiocast, Q3'26
Language: English11/10/2026, 9:00 AM
Lotta Borgström Good morning, everyone, and welcome to the Mandatum Q3 2026 audiocast. My name is Lotta Borgström from Investor Relations. Joining me today are our CEO, Petri Niemisvirta, and our CFO,…
Solar foods Go-to-market Update
Language: English11/9/2026, 12:00 PM
Maria Hello everyone, and welcome to the Solar Foods go-to-market update. My name is Maria and I'm here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is Heli…
Outokumpu, Webcast, Q3'26
Language: English11/6/2026, 12:30 PM
Johan Welcome to the third quarter results webcast. I am responsible for investor relations. We will start with the presentation from our CEO, Kati ter Horst, and our CFO, Marc-Simon Schaar. After the…
Endomines, Webcast, Q3'26
Language: English11/5/2026, 1:00 PM
Andy Turpin Hello, everyone, and welcome to Endomines' third-quarter results webcast. Thanks for joining us today. My name is Andy Turpin and I am the Chief Communications Officer here at Endomines. A…
Lemonsoft Oyj, Q3'26 webcast
Language: English11/5/2026, 11:00 AM
Unknown 1 Welcome to the Lemonsoft Q3 results presentation. We will start with the presentation from CEO Alpo Luostarinen, followed by the Q&A. You can send your questions throughout the event via the…
Enersense, Webcast, Q3'26
Language: English11/5/2026, 10:30 AM
Liisa Tamminen Hello and welcome to the Enersense Q3 2026 results webcast. My name is Liisa Tamminen from Enersense Investor Relations. And with me here I have our CEO, Kari Sundbäck, and CFO, Jan-Elo…
Sitowise, Q3'26
Language: English11/5/2026, 10:00 AM
Mari Reponen Good day everyone, and welcome to the Sitowise Q3 2026 results audiocast. My name is Mari Reponen, and I am responsible for strategy and IR here at Sitowise. And today with me are our act…
Orthex, Webcast, Q3'26
Language: English11/5/2026, 9:00 AM
Alexander Rosenlew Good morning and welcome to the Orthex Interim Report. My name is Alexander Rosenlew and with me I have Saara Mäkelä, CFO, and Hanna Kukkonen, our CMSO. We will take you through the…
Suominen Oyj, Q3'26
Language: English11/5/2026, 8:30 AM
Anni Luoma Good morning, everyone, and welcome to the Suominen Q3 webcast. My name is Anni Luoma. I am the Manager of External Communications and Investor Relations at Suominen. Here with me are our P…
Lumo, Webcast, Q3'26
Language: English11/5/2026, 8:00 AM
Niina Saarto Good morning, all. Welcome. This is Lumo Homes plc's third quarter result webcast. I am Niina Saarto from Treasury and Investor Relations. Today I have two gentlemen here with me, namely…
CapMan, Webcast, Q3'26
Language: English11/5/2026, 7:30 AM
Charlotte Good morning and welcome to this presentation of CapMan. Q3 2026 interim report. Presenting today we have Pia Kåll, CEO of CapMan. And after the presentation, we will have a Q&A session. You…
Marimekko, Webcast, Q3'26
Language: English11/4/2026, 12:00 PM
Anna Good afternoon. My name is Anna and I am the IRO of Marimekko. It is my pleasure to welcome you to our Q3 webcast. With me, I have our president and CEO, Tiina Alahuhta, who will walk you through…
Administer, Webcast, Q3'26
Language: Finnish11/4/2026, 9:00 AM
Kimmo Herranen Welcome to the Administer Q3 2026 interim report. Results. Meillä on se alkaa. I am Kimmo Herranen. Kalle Lehtonen. Also. Kaarina og. Yelken. Kalle Lehtonen En el coco. Madan. Parannus.…
Kempower, Webcast, Q3'26
Language: English11/4/2026, 8:30 AM
Unknown 1 Powering the planet. Kempower. We charge our planet for the better. By powering the electric movement. We enable quick and scalable EV charging solutions for everyone and everywhere. We ma…